Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Patient Satisfaction × Alfentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 2 Neoplasms 2 Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Patient Satisfaction 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lung Neoplasms 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1

Interventions

Surveys and Questionnaires 3 Surgical Procedures, Operative 2 Propofol 2 delta 24-sterol reductase 1 daratumumab 1 Vascular Access Devices 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Parapsychology 1 Music Therapy 1 Midazolam 1 Lidocaine 1 Imiquimod 1 Ibuprofen 1 Fentanyl 1 Exercise 1 Drainage 1 Control Groups 1 Colonoscopy 1 Bandages, Hydrocolloid 1 Alfentanil 1 Aftercare 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05688384 2024-11-12

PACSPI-2

Region Jönköping County

Phase 4 Completed

Neoplasms, Pain, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡